LobbyingHalocarbon Life Sciences lobbying by quarter
Halocarbon Life Sciences's latest lobbying report covers Q1 2025, at $10K. Its first report covers Q4 2024; the issues it reports most are Miscellaneous Tariff Bills.
Halocarbon Life Sciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2024 | $30K | 1 |
| Q1 2025 | $10K | 1 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Tariffs$40K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Innovative Federal Strategies | $40K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/04/16for Q1 2025 | Innovative Federal Strategies | $10K |
| 25/01/20for Q4 2024 | Innovative Federal Strategies | $30K |
| 25/01/14for Q4 2024 | Innovative Federal Strategies | Under $5,000 |